Profile Picture
Rewards
  • Search
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
    • Real Estate
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Decade-long affair with dad
5 homeless people shot
Makes rare public outing
Earthquake hits Philippines
Culkin honored with star
Activated off IR
Domestic violence arrest
Parts ways with Jets
Meets families of hostages
Moscow's gay bars raided
In-N-Out Burger tycoon dies
Quitting 'BBC Radio 2' show
Mount Etna erupts
USC hires D'Anton Lynn
Heavy snowfall halts flights
Jackpot reaches $355M
Calls for end to fossil fuels
10th on all-time scoring list
Rule to cut methane emissions
Israeli airstrike on Syria
Dejected after loss
GPT store delayed to 2024
Season 2 trailer
Make red carpet debut
$3B for Green Climate Fund
Plan to protect Canada lynx
Snooker champ to reach final
BMW recalls SUVs
Nuggets defeat Suns
Dolphins elevate Conner
US to phase out coal power
‘Renaissance' box office
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
3,890 results
The Messenger on MSN1d
Pfizer Suffers Setback in Weight Loss Trial After Patients Drop Pill Due to Uncomfortable Side Effects
While Wegovy, Ozempic and Zepbound soar, other weight loss medications are struggling.
Reuters1d
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Dr. Lee Kaplan took the stage with an urgent message, telling fellow physicians they have a powerful weapon to fight the ...
3don MSN
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real-world study says
Patients on Eli Lilly's Mounjaro were more likely to lose weight and experienced larger reductions in body weight compared to ...
3mon
Wegovy weight-loss drugmaker sees profits soar
The maker of weight-loss jabs Wegovy and Ozempic, Danish pharmaceutical giant Novo Nordisk, has reported a sharp rise in ...
The Motley Fool29d
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
Novo Nordisk delivered sizzling Q3 growth, thanks mainly to soaring sales for Ozempic. However, Eli Lilly's Q3 results looked even better than Novo Nordisk's. Both stocks could be winners for ...
Futurism2mon
Snack Food CEO Vows to Battle Ozempic
As the popularity of appetite-suppressing drugs like Ozempic and Wegovy continues to skyrocket, one of America's chief snack food overlords is readying himself — and his company's delicious ...
Healthline17d
Black People Are Facing Greater Challenges Accessing Anti-Obesity Drugs Like Ozempic and Wegovy
Share on Pinterest Diabetes and obesity disproportionately impact Black people, yet they are facing greater challenges gaining access to GLP-1 medications like Ozempic that could help treat these ...
Medindia16d
Medications and their Potential to Cause Increase 'Throat sore'
This section presents medications that are known to potentially lead to 'Throat sore' as a side effect." It's important to note that mild side effects are quite common with medications. Please be ...
BioPharma Dive
1d
European regulators want to know more about the risks of GLP-1 drugs
The EMA's safety committee has more questions for makers of the in-demand therapies as it reviews whether the drugs are linked to the risk of suicidal thoughts.
The Guardian1mon
Sales soar at Danish firm behind weight-loss drug semaglutide
Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and ...
Hosted on MSN29d
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
Is the fervor over Ozempic just a passing fad? It doesn't appear to be the case after Novo Nordisk (NYSE: NVO) announced its results for the first nine months of 2023 on Thursday morning.
BBC3mon
Wegovy weight-loss drugmaker sees profits soar
The maker of weight-loss jabs Wegovy and Ozempic, Danish pharmaceutical giant Novo Nordisk, has reported a sharp rise in profits on the back of surging demand for the drugs. Net profits were 39 ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Get the Bing App
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices